amyotrophic lateral sclerosis

Graphic of a dart right on a bullseye sun breaking through the clouds in the background

Biotech

Otsuka heads to FDA as Ionis-allied ALS drug hits primary goal

A phase 3 study of Otsuka and Ionis’ ALS prospect hit its primary endpoint, positioning the partners to talk to regulators about expedited approvals.

Nick Paul Taylor Sep 22, 2026 9:22am

Darts failing to hit bullseye

Novartis ends ALS program after phase 2 flop, adding to R&D woes

Sep 16, 2026 10:28am

Axoltis misses the mark in phase 2 ALS study but will persevere with the synthetic peptide

Axoltis misses the mark in ph. 2 ALS study, but won't give up

Sep 15, 2026 3:00am

A small plant growing in a crack in the ground with a shadow of a tree behind it

Verge drops sole clinical candidate in return to AI roots

Dec 18, 2025 10:04pm

sailing boat water yacht ocean wind

Voyager sets sail on neuro research trek with Transition Bio

Nov 10, 2025 5:23pm

human brain abstract art

Thermo Fisher debuts protein panel for neurodegeneration R&D

Sep 16, 2025 12:00pm